| Issue Date | Title | Author(s) |
| 8-Apr-2016 | A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort. | Terry, KL; Schock, H; Fortner, RT; Hüsing, A; Fichorova, RN, et al |
| 28-Feb-2017 | Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort. | Hüsing, A; Fortner, RT; Kühn, T; Overvad, K; Tjønneland, A, et al |
| 20-Mar-2017 | Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort. | Fortner, RT; Vitonis, AF; Schock, H; Hüsing, A; Johnson, T, et al |
| 4-Jan-2021 | Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score. | Aleksandrova, K; Reichmann, R; Kaaks, R; Jenab, M; Bueno-de-Mesquita, HB, et al |
| 11-Dec-2017 | Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: results from the EPIC cohort | Fortner, RT; Schock, H; Le Cornet, C; Hüsing, A; Vitonis, AF, et al |
| 21-Aug-2019 | Pre-diagnostic plasma bile acid levels and colon cancer risk: A prospective study | Kühn, T; Stepien, M; López-Nogueroles, M; Machado, AD; Sookthai, D, et al |
| 3-Dec-2018 | Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts | Li, K; Anderson, G; Viallon, V; Arveux, P; Kvaskoff, M, et al |
| 1-Feb-2018 | Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation. | Kaaks, R; Fortner, RT; Hüsing, A; Barrdahl, M; Hopper, M, et al |